Deregulation of Cdc2 kinase induces caspase-3 activation and apoptosis.

TitleDeregulation of Cdc2 kinase induces caspase-3 activation and apoptosis.
Publication TypeJournal Article
Year of Publication2003
AuthorsGu L, Zheng H, Murray SA, Ying H, Xiao Z-XJim
JournalBiochem Biophys Res Commun
Volume302
Issue2
Pagination384-91
Date Published2003 Mar 07
ISSN0006-291X
KeywordsAnimals, Apoptosis, Caspase 3, Caspases, CDC2 Protein Kinase, Cell Extracts, Cyclin B, Cyclin B1, Enzyme Activation, HeLa Cells, Humans, Interphase, Mitosis, Nuclear Proteins, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-mdm2, Xenopus, Xenopus Proteins
Abstract

Progression of the cell cycle and control of apoptosis are tightly linked processes. It has been reported that manifestation of apoptosis requires cdc2 kinase activity yet the mechanism(s) of which is largely unclear. In an attempt to study the role of human MDM2 (HDM2) in interphase and mitosis, we employed the Xenopus cell-free system to study HDM2 protein stability. Interestingly, HDM2 is specifically cleaved in Xenopus mitotic extracts but not in the interphase extracts. We demonstrate that HDM2 cleavage is dependent on caspase-3 and that activation of cdc2 kinase results in caspase-3 activation in the Xenopus cell-free system. Furthermore, expression of cdc2 kinase in mammalian cells leads to activation of caspase-3 and apoptosis. Taken together, these data indicate that deregulation of cdc2 kinase activity can trigger apoptotic machinery that leads to caspase-3 activation and apoptosis.

DOI10.1016/s0006-291x(03)00189-x
Alternate JournalBiochem Biophys Res Commun
PubMed ID12604359
Grant ListR01CA79804 / CA / NCI NIH HHS / United States
Related Faculty: 
Hongwu Zheng, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700